UK markets open in 2 hours 1 minute

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.58-0.42 (-3.00%)
At close: 04:00PM EDT
13.57 -0.01 (-0.07%)
After hours: 07:41PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts18182019
Avg. Estimate-1.65-1.64-6.39-4.89
Low estimate-2.16-2-7.98-7.09
High estimate-1.26-1.02-3.962.56
Year ago EPS-2.46-2.68-9.05-6.39
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts17171919
Avg. Estimate5.78M7.1M34.16M137.45M
Low estimate2.12M2.45M14.14M35.57M
High estimate15.08M15.58M80.22M528.73M
Year ago sales2.41M2.47M86.45M34.16M
Sales growth (year/est)139.80%187.40%-60.50%302.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-2.5-2.55-2.73-1.28
Actual EPS-2.46-2.68-3.37-0.55
Difference0.04-0.13-0.640.73
Surprise %1.60%-5.10%-23.40%57.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-1.65-1.64-6.39-4.89
7 days ago-1.62-1.61-6.4-4.86
30 days ago-1.6-1.58-6.22-4.76
60 days ago-1.6-1.58-6.3-4.9
90 days ago-1.46-1.74-6.14-5.24
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days12N/AN/A
Up last 30 days4444
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesSAGEIndustrySector(s)S&P 500
Current qtr.32.90%N/AN/AN/A
Next qtr.38.80%N/AN/AN/A
Current year29.40%N/AN/AN/A
Next year23.50%N/AN/AN/A
Next 5 years (per annum)16.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A